Skip to Content

9 3 7160 (Pergolide Mesylate 0.05 mg)

Pill with imprint 9 3 7160 is White, Elliptical / Oval and has been identified as Pergolide Mesylate 0.05 mg. It is supplied by Teva Pharmaceuticals USA.

Pergolide is used in the treatment of hyperprolactinemia; parkinson's disease; tourette's syndrome and belongs to the drug class dopaminergic antiparkinsonism agents. There is no proven risk in humans during pregnancy. Pergolide 0.05 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 9 3 7160

Pergolide mesylate 0.05 mg 9 3 7160

Pergolide Mesylate

9 3 7160
0.05 mg
Elliptical / Oval
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
National Drug Code (NDC)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.